Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial)

Detalles Bibliográficos
Autores principales: Bug, G, Burchert, A, Wagner, E-M, Kröger, N, Berg, T, Güller, S, Metzelder, S K, Wolf, A, Hünecke, S, Bader, P, Schetelig, J, Serve, H, Ottmann, O G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668491/
https://www.ncbi.nlm.nih.gov/pubmed/28751769
http://dx.doi.org/10.1038/leu.2017.242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668491/
https://www.ncbi.nlm.nih.gov/pubmed/28751769
http://dx.doi.org/10.1038/leu.2017.242

Ejemplares similares